Haven't seen anybody mention this yet from the latest report.
Under - Exploring Non-core Opportunities "Provided non-core activities are well controlled and qualified then they both add to value creation using Mix&Go technology and improve the core competency of the organisation.
At this time Anteo has two non-core projects underway - one in Clean Technology and one in Medical Devices. Both are showing good promise."
So I take it that the POC1 device is the medical device being referred to here, which is outside their core opportunities.
This leads me to ask the question as to whether the revenue return from any deal struck here would be as big as some are saying??
ADO Price at posting:
9.6¢ Sentiment: Hold Disclosure: Held
